Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in sun pharmaceutical industries

Lupin launches Favipiravir in India for COVID treatment at Rs 49 per tablet

Lupin launches Favipiravir in India for COVID treatment at Rs 49 per tablet

Read More

Sun Pharma's arm Taro achieves global resolution of US DoJ anti-trust probes

Sun Pharma's arm Taro achieves global resolution of US DoJ anti-trust probes

Read More

Sun Pharma Q2 Profit More Than Doubles, Beats Estimates

Sales in its largest market, the United States, rose 9 per cent, while those in India rose 11 per cent. In emerging markets, Sun's sales rose 22 per cent

Read More

Sun Pharma: Strong Biz Acumen

Shanghvi’s “patient approach” in fighting the odds helped Sun Pharma to scale up to the current level

Read More

Sun Pharma Slumps After US Issues Warning On Standards Violations

The warning comes barely a month after rival Dr Reddy's Laboratories Ltd was reprimanded by the US Food and Drug Administration for issues including record-keeping at three of its plants

Read More

US FDA Warns Sun Pharma Over Standards At Halol Plant

The Halol plant makes up about 15 percent of Sun Pharma's sales in its largest market, the United States. It is critical to the company as it has the capabilities to manufacture injectable products

Read More